E-LIB Suche - Ergebnisse für: Chien, Kelly

1

Influence of co-mutational patterns in disease phenotype an..:

Montalban-Bravo, Guillermo ; Rodriguez-Sevilla, Juan Jose ; Swanson, David Michael...
Leukemia. 38 (2024) 5 - p. 1178-1181 , 2024

Link: https://doi.org/10.1038/..

2

Phase 1 study of azacitidine in combination with quizartini..:

Montalban-Bravo, Guillermo ; Jabbour, Elias ; Chien, Kelly...
Leukemia Research. 142 (2024) - p. 107518 , 2024

Link: https://doi.org/10.1016/..

3

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology. 11 (2024) 3 - p. e186-e195 , 2024

Link: https://doi.org/10.1016/..

4

Eosinophilia During Lenalidomide Therapy in Myelodysplastic..:

Sasaki, Koji ; Kantarjian, Hagop ; Montalban-Bravo, Guillermo...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

5

ASXL1/TET2 genotype-based risk stratification outperforms A..:

Csizmar, Clifford M. ; Gurney, Mark ; Kanagal-Shamanna, Rashmi...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology. 11 (2024) 4 - p. e287-e298 , 2024

Link: https://doi.org/10.1016/..

7

Hematopoietic stem cells with granulo-monocytic differentia..:

Rodriguez-Sevilla, Juan Jose ; Ganan-Gomez, Irene ; Ma, Feiyang...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Chien, Kelly ; Urrutia, Samuel ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e08202e6 , 2023

Link: https://doi.org/10.1097/..

9

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e554617b , 2023

Link: https://doi.org/10.1097/..

10

S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLIN..:

Short, Nicholas ; Jabbour, Elias ; Jain, Nitin...
HemaSphere. 7 (2023) S3 - p. e4968152 , 2023

Link: https://doi.org/10.1097/..

11

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
HemaSphere. 7 (2023) S3 - p. e18588ff , 2023

Link: https://doi.org/10.1097/..

12

Targeted therapy with the mutant IDH2 inhibitor enasidenib ..:

DiNardo, Courtney D. ; Venugopal, Sangeetha ; Lachowiez, Curtis...
Blood Advances. 7 (2023) 11 - p. 2378-2387 , 2023

Link: https://doi.org/10.1182/..

13

30. Chromosomal microarray analysis work-up for hypocellula..:

Nguyen, Ha ; Xu, Fangling ; Raju, Sherin...
Cancer Genetics. 278-279 (2023) - p. 9-10 , 2023

Link: https://doi.org/10.1016/..

14

P377: A PHASE II TRIAL OF MINI-HYPER-CVD WITH VENETOCLAX FO..:

Haddad, Fadi ; Jabbour, Elias ; Zoghbi, Marianne...
HemaSphere. 7 (2023) S3 - p. e9487430 , 2023

Link: https://doi.org/10.1097/..

15

P748: IPSS-M PERFORMANCE IN PATIENTS WITH MYELODYSPLASTIC S..:

Urrutia, Samuel ; Chien, Kelly ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e23789ce , 2023

Link: https://doi.org/10.1097/..